Targeting NRP1 with EG00229 induces neurovascular permeability

Silvia Dragoni,James T Brash,Alessandro Fantin,Charles Burridge,Laura Denti,Patric Turowski,Christiana Ruhrberg

DOI: https://doi.org/10.1101/2023.11.07.564946

2024-07-09

Abstract:NRP1 is a therapeutic target to inhibit vascular endothelial growth factor (VEGF)-induced blood vessel dysfunction. The small molecule EG00229 inhibits VEGF binding to NRP1 and reduces pathological blood vessel growth. However, it is unknown whether it could be used to reduce VEGF164-induced vascular leakage, which often exacerbates ischemic diseases due to VEGF upregulation. Here, we show that EG00229 increased rather than inhibited vascular leakage in perfused retinal explants and across primary brain EC monolayers, either when added alone or together with VEGF164. EG00229-induced vascular leakage was not an off-target effect, because it required its intended target, endothelial NRP1 expression and NRP1's VEGF164 binding pocket, but was independent of VEGFR1 and VEGFR2. Moreover, EG00229 activated molecular events typical of VEGF164-induced paracellular permeability, including p38 MAP kinase (p38) and SRC family kinase (SFK) phosphorylation as well as endothelial junction rearrangement. Investigating EG00229-induced signalling therefore helps elucidate NRP1-dependent mechanisms of paracellular permeability induction and, in the future, might also help identify new approaches to modulate the neurovascular barrier.

Physiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the effect of the small molecule EG00229 on retinal vascular permeability and its mechanism. Specifically, the researchers wanted to know whether EG00229 could reduce the vascular leakage induced by VEGF164, which is often exacerbated by the up - regulation of VEGF in ischemic diseases. However, the study found that EG00229 not only did not inhibit the vascular leakage caused by VEGF164, but instead increased the vascular permeability. Therefore, the study further explored the mechanism of this unexpected finding, especially how EG00229 increases vascular permeability through the NRP1 - dependent pathway, independent of VEGFR1 or VEGFR2.

The key points of the study include:
1. **Effect of EG00229 on vascular permeability**: The study found that when EG00229 was used alone or in combination with VEGF164, it could increase the permeability of retinal microvessels.
2. **Role of NRP1**: The vascular leakage induced by EG00229 is dependent on the expression of NRP1 in endothelial cells, especially the VEGF164 - binding pocket of NRP1.
3. **Signal transduction mechanism**: EG00229 activates molecular events similar to the paracellular permeability induced by VEGF164, including the phosphorylation of p38 MAP kinase (p38) and SRC family kinase (SFK) and the rearrangement of CDH5 at endothelial cell junctions.
4. **Receptor specificity**: The vascular leakage induced by EG00229 is independent of VEGFR1 or VEGFR2, but is mediated through the C - terminal rule (CendR) pocket of NRP1.

These findings help to clarify the NRP1 - dependent paracellular permeability - induction mechanism and may provide new strategies for regulating the neurovascular barrier.